Loading…
Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation
The usefulness of routine axillary dissection (AD) at levels I-II in breast cancer patients has been questioned for years because of the high postoperative morbidity in the shoulder and arm region, and the increasing number of patients with negative nodes. Sentinel node biopsy (SNB) was hoped both t...
Saved in:
Published in: | Breast cancer research and treatment 2002-05, Vol.73 (1), p.31-36 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c350t-3b290fa74d4d0c57459ea949f1c7ec2bafa01ab69bdafb33cbcfbb1b0b3c1be03 |
---|---|
cites | cdi_FETCH-LOGICAL-c350t-3b290fa74d4d0c57459ea949f1c7ec2bafa01ab69bdafb33cbcfbb1b0b3c1be03 |
container_end_page | 36 |
container_issue | 1 |
container_start_page | 31 |
container_title | Breast cancer research and treatment |
container_volume | 73 |
creator | HAID, Anton KÖBERLE-WÜHRER, Roswitha ZIMMERMANN, Gerhard KNAUER, Michael BURTSCHER, Judit FRITZSCHE, Heinz PESCHINA, William JASAREVIC, Zerina AMMANN, Maria HERGAN, Klaus STURN, Heinz |
description | The usefulness of routine axillary dissection (AD) at levels I-II in breast cancer patients has been questioned for years because of the high postoperative morbidity in the shoulder and arm region, and the increasing number of patients with negative nodes. Sentinel node biopsy (SNB) was hoped both to reduce morbidity and to improve the reliability of staging. This study was designed to provide more evidence in this matter by comparing the follow-up data of patients with AD and those with SNB only.
One hundred forty patients who had undergone AD between 1993 and 1996 were questioned for their subjective and objective symptoms using a questionnaire and subsequently subjected to a clinical examination. Their data were compared with those of 57 patients who had undergone SNB only between 1998 and 2000.
Local recurrences have not been seen to date. The difference between the two groups in terms of a loss of quality of life was negligible. The differences in overall complaints, number of symptoms, pain, limited range of motion of the operated upper extremity, numbness, paresthesias, and arm swelling as well as perceived disability in activities of daily living were significantly in favor of SNB. The length of hospital stay was significantly shorter for SNB patients.
SNB appears to be an accurate procedure for axillary nodal staging in breast cancer patients and is associated with reduced postoperative morbidity and length of hospital stay. But it is still investigational and should not be implemented as therapeutical standard before results of randomized trials are published. |
doi_str_mv | 10.1023/A:1015234318582 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71849575</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>405244721</sourcerecordid><originalsourceid>FETCH-LOGICAL-c350t-3b290fa74d4d0c57459ea949f1c7ec2bafa01ab69bdafb33cbcfbb1b0b3c1be03</originalsourceid><addsrcrecordid>eNpdkU1v1DAQhi1ERbeFMzdkIdFbqD_iOO5tVbWAVMQFztHYGSNX3jjYScse-ed16UoVnHx53mfG8xLylrOPnAl5vr3gjCshW8l71YsXZMOVlo0WXL8kG8Y73XQ9647JSSm3jDGjmXlFjrlgveyE2ZA_X1O2YQzLniZPbUYoC3UwOcx0hiXgtBTqU4zpPkw_qUu7OeKCFH6HGCHv6RhKQbeENNGUaal8mDDSKY1IbUhzqeIp7i8o_A1DrtI7pHgHcYXH2Gty5CEWfHN4T8mP66vvl5-bm2-fvlxubxonFVsaaYVhHnQ7tiNzSrfKIJjWeO40OmHBA-NgO2NH8FZKZ523lltmpeMWmTwlZ0_eOadfK5Zl2IXisP5iwrSWQfO-NUqrCr7_D7xNa57qboPgolWy67sKnT9BLqdSMvphzmFXDzJwNjxWM2yHf6qpiXcH7Wp3OD7zhy4q8OEAQHEQfa4thPLM1bnaVOEDYFOZ1Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>212453686</pqid></control><display><type>article</type><title>Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation</title><source>Springer Link</source><creator>HAID, Anton ; KÖBERLE-WÜHRER, Roswitha ; ZIMMERMANN, Gerhard ; KNAUER, Michael ; BURTSCHER, Judit ; FRITZSCHE, Heinz ; PESCHINA, William ; JASAREVIC, Zerina ; AMMANN, Maria ; HERGAN, Klaus ; STURN, Heinz</creator><creatorcontrib>HAID, Anton ; KÖBERLE-WÜHRER, Roswitha ; ZIMMERMANN, Gerhard ; KNAUER, Michael ; BURTSCHER, Judit ; FRITZSCHE, Heinz ; PESCHINA, William ; JASAREVIC, Zerina ; AMMANN, Maria ; HERGAN, Klaus ; STURN, Heinz</creatorcontrib><description>The usefulness of routine axillary dissection (AD) at levels I-II in breast cancer patients has been questioned for years because of the high postoperative morbidity in the shoulder and arm region, and the increasing number of patients with negative nodes. Sentinel node biopsy (SNB) was hoped both to reduce morbidity and to improve the reliability of staging. This study was designed to provide more evidence in this matter by comparing the follow-up data of patients with AD and those with SNB only.
One hundred forty patients who had undergone AD between 1993 and 1996 were questioned for their subjective and objective symptoms using a questionnaire and subsequently subjected to a clinical examination. Their data were compared with those of 57 patients who had undergone SNB only between 1998 and 2000.
Local recurrences have not been seen to date. The difference between the two groups in terms of a loss of quality of life was negligible. The differences in overall complaints, number of symptoms, pain, limited range of motion of the operated upper extremity, numbness, paresthesias, and arm swelling as well as perceived disability in activities of daily living were significantly in favor of SNB. The length of hospital stay was significantly shorter for SNB patients.
SNB appears to be an accurate procedure for axillary nodal staging in breast cancer patients and is associated with reduced postoperative morbidity and length of hospital stay. But it is still investigational and should not be implemented as therapeutical standard before results of randomized trials are published.</description><identifier>ISSN: 0167-6806</identifier><identifier>EISSN: 1573-7217</identifier><identifier>DOI: 10.1023/A:1015234318582</identifier><identifier>PMID: 12083629</identifier><identifier>CODEN: BCTRD6</identifier><language>eng</language><publisher>Dordrecht: Springer</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Axilla ; Biological and medical sciences ; Breast cancer ; Breast Neoplasms - diagnosis ; Breast Neoplasms - epidemiology ; Cancer research ; Cancer therapies ; Female ; Follow-Up Studies ; Gynecology. Andrology. Obstetrics ; Humans ; Lymph Node Excision ; Lymph Nodes - pathology ; Mammary gland diseases ; Mastectomy ; Medical sciences ; Middle Aged ; Neoplasm Staging ; Sentinel Lymph Node Biopsy ; Tumors</subject><ispartof>Breast cancer research and treatment, 2002-05, Vol.73 (1), p.31-36</ispartof><rights>2002 INIST-CNRS</rights><rights>Copyright Kluwer Academic Publishers May 2002</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c350t-3b290fa74d4d0c57459ea949f1c7ec2bafa01ab69bdafb33cbcfbb1b0b3c1be03</citedby><cites>FETCH-LOGICAL-c350t-3b290fa74d4d0c57459ea949f1c7ec2bafa01ab69bdafb33cbcfbb1b0b3c1be03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13687952$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12083629$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HAID, Anton</creatorcontrib><creatorcontrib>KÖBERLE-WÜHRER, Roswitha</creatorcontrib><creatorcontrib>ZIMMERMANN, Gerhard</creatorcontrib><creatorcontrib>KNAUER, Michael</creatorcontrib><creatorcontrib>BURTSCHER, Judit</creatorcontrib><creatorcontrib>FRITZSCHE, Heinz</creatorcontrib><creatorcontrib>PESCHINA, William</creatorcontrib><creatorcontrib>JASAREVIC, Zerina</creatorcontrib><creatorcontrib>AMMANN, Maria</creatorcontrib><creatorcontrib>HERGAN, Klaus</creatorcontrib><creatorcontrib>STURN, Heinz</creatorcontrib><title>Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation</title><title>Breast cancer research and treatment</title><addtitle>Breast Cancer Res Treat</addtitle><description>The usefulness of routine axillary dissection (AD) at levels I-II in breast cancer patients has been questioned for years because of the high postoperative morbidity in the shoulder and arm region, and the increasing number of patients with negative nodes. Sentinel node biopsy (SNB) was hoped both to reduce morbidity and to improve the reliability of staging. This study was designed to provide more evidence in this matter by comparing the follow-up data of patients with AD and those with SNB only.
One hundred forty patients who had undergone AD between 1993 and 1996 were questioned for their subjective and objective symptoms using a questionnaire and subsequently subjected to a clinical examination. Their data were compared with those of 57 patients who had undergone SNB only between 1998 and 2000.
Local recurrences have not been seen to date. The difference between the two groups in terms of a loss of quality of life was negligible. The differences in overall complaints, number of symptoms, pain, limited range of motion of the operated upper extremity, numbness, paresthesias, and arm swelling as well as perceived disability in activities of daily living were significantly in favor of SNB. The length of hospital stay was significantly shorter for SNB patients.
SNB appears to be an accurate procedure for axillary nodal staging in breast cancer patients and is associated with reduced postoperative morbidity and length of hospital stay. But it is still investigational and should not be implemented as therapeutical standard before results of randomized trials are published.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Axilla</subject><subject>Biological and medical sciences</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - diagnosis</subject><subject>Breast Neoplasms - epidemiology</subject><subject>Cancer research</subject><subject>Cancer therapies</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Lymph Node Excision</subject><subject>Lymph Nodes - pathology</subject><subject>Mammary gland diseases</subject><subject>Mastectomy</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>Sentinel Lymph Node Biopsy</subject><subject>Tumors</subject><issn>0167-6806</issn><issn>1573-7217</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNpdkU1v1DAQhi1ERbeFMzdkIdFbqD_iOO5tVbWAVMQFztHYGSNX3jjYScse-ed16UoVnHx53mfG8xLylrOPnAl5vr3gjCshW8l71YsXZMOVlo0WXL8kG8Y73XQ9647JSSm3jDGjmXlFjrlgveyE2ZA_X1O2YQzLniZPbUYoC3UwOcx0hiXgtBTqU4zpPkw_qUu7OeKCFH6HGCHv6RhKQbeENNGUaal8mDDSKY1IbUhzqeIp7i8o_A1DrtI7pHgHcYXH2Gty5CEWfHN4T8mP66vvl5-bm2-fvlxubxonFVsaaYVhHnQ7tiNzSrfKIJjWeO40OmHBA-NgO2NH8FZKZ523lltmpeMWmTwlZ0_eOadfK5Zl2IXisP5iwrSWQfO-NUqrCr7_D7xNa57qboPgolWy67sKnT9BLqdSMvphzmFXDzJwNjxWM2yHf6qpiXcH7Wp3OD7zhy4q8OEAQHEQfa4thPLM1bnaVOEDYFOZ1Q</recordid><startdate>20020501</startdate><enddate>20020501</enddate><creator>HAID, Anton</creator><creator>KÖBERLE-WÜHRER, Roswitha</creator><creator>ZIMMERMANN, Gerhard</creator><creator>KNAUER, Michael</creator><creator>BURTSCHER, Judit</creator><creator>FRITZSCHE, Heinz</creator><creator>PESCHINA, William</creator><creator>JASAREVIC, Zerina</creator><creator>AMMANN, Maria</creator><creator>HERGAN, Klaus</creator><creator>STURN, Heinz</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9-</scope><scope>K9.</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20020501</creationdate><title>Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation</title><author>HAID, Anton ; KÖBERLE-WÜHRER, Roswitha ; ZIMMERMANN, Gerhard ; KNAUER, Michael ; BURTSCHER, Judit ; FRITZSCHE, Heinz ; PESCHINA, William ; JASAREVIC, Zerina ; AMMANN, Maria ; HERGAN, Klaus ; STURN, Heinz</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c350t-3b290fa74d4d0c57459ea949f1c7ec2bafa01ab69bdafb33cbcfbb1b0b3c1be03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Axilla</topic><topic>Biological and medical sciences</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - diagnosis</topic><topic>Breast Neoplasms - epidemiology</topic><topic>Cancer research</topic><topic>Cancer therapies</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Lymph Node Excision</topic><topic>Lymph Nodes - pathology</topic><topic>Mammary gland diseases</topic><topic>Mastectomy</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>Sentinel Lymph Node Biopsy</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HAID, Anton</creatorcontrib><creatorcontrib>KÖBERLE-WÜHRER, Roswitha</creatorcontrib><creatorcontrib>ZIMMERMANN, Gerhard</creatorcontrib><creatorcontrib>KNAUER, Michael</creatorcontrib><creatorcontrib>BURTSCHER, Judit</creatorcontrib><creatorcontrib>FRITZSCHE, Heinz</creatorcontrib><creatorcontrib>PESCHINA, William</creatorcontrib><creatorcontrib>JASAREVIC, Zerina</creatorcontrib><creatorcontrib>AMMANN, Maria</creatorcontrib><creatorcontrib>HERGAN, Klaus</creatorcontrib><creatorcontrib>STURN, Heinz</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Consumer Health Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Breast cancer research and treatment</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HAID, Anton</au><au>KÖBERLE-WÜHRER, Roswitha</au><au>ZIMMERMANN, Gerhard</au><au>KNAUER, Michael</au><au>BURTSCHER, Judit</au><au>FRITZSCHE, Heinz</au><au>PESCHINA, William</au><au>JASAREVIC, Zerina</au><au>AMMANN, Maria</au><au>HERGAN, Klaus</au><au>STURN, Heinz</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation</atitle><jtitle>Breast cancer research and treatment</jtitle><addtitle>Breast Cancer Res Treat</addtitle><date>2002-05-01</date><risdate>2002</risdate><volume>73</volume><issue>1</issue><spage>31</spage><epage>36</epage><pages>31-36</pages><issn>0167-6806</issn><eissn>1573-7217</eissn><coden>BCTRD6</coden><abstract>The usefulness of routine axillary dissection (AD) at levels I-II in breast cancer patients has been questioned for years because of the high postoperative morbidity in the shoulder and arm region, and the increasing number of patients with negative nodes. Sentinel node biopsy (SNB) was hoped both to reduce morbidity and to improve the reliability of staging. This study was designed to provide more evidence in this matter by comparing the follow-up data of patients with AD and those with SNB only.
One hundred forty patients who had undergone AD between 1993 and 1996 were questioned for their subjective and objective symptoms using a questionnaire and subsequently subjected to a clinical examination. Their data were compared with those of 57 patients who had undergone SNB only between 1998 and 2000.
Local recurrences have not been seen to date. The difference between the two groups in terms of a loss of quality of life was negligible. The differences in overall complaints, number of symptoms, pain, limited range of motion of the operated upper extremity, numbness, paresthesias, and arm swelling as well as perceived disability in activities of daily living were significantly in favor of SNB. The length of hospital stay was significantly shorter for SNB patients.
SNB appears to be an accurate procedure for axillary nodal staging in breast cancer patients and is associated with reduced postoperative morbidity and length of hospital stay. But it is still investigational and should not be implemented as therapeutical standard before results of randomized trials are published.</abstract><cop>Dordrecht</cop><pub>Springer</pub><pmid>12083629</pmid><doi>10.1023/A:1015234318582</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0167-6806 |
ispartof | Breast cancer research and treatment, 2002-05, Vol.73 (1), p.31-36 |
issn | 0167-6806 1573-7217 |
language | eng |
recordid | cdi_proquest_miscellaneous_71849575 |
source | Springer Link |
subjects | Adult Aged Aged, 80 and over Axilla Biological and medical sciences Breast cancer Breast Neoplasms - diagnosis Breast Neoplasms - epidemiology Cancer research Cancer therapies Female Follow-Up Studies Gynecology. Andrology. Obstetrics Humans Lymph Node Excision Lymph Nodes - pathology Mammary gland diseases Mastectomy Medical sciences Middle Aged Neoplasm Staging Sentinel Lymph Node Biopsy Tumors |
title | Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T09%3A21%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Morbidity%20of%20breast%20cancer%20patients%20following%20complete%20axillary%20dissection%20or%20sentinel%20node%20biopsy%20only:%20a%20comparative%20evaluation&rft.jtitle=Breast%20cancer%20research%20and%20treatment&rft.au=HAID,%20Anton&rft.date=2002-05-01&rft.volume=73&rft.issue=1&rft.spage=31&rft.epage=36&rft.pages=31-36&rft.issn=0167-6806&rft.eissn=1573-7217&rft.coden=BCTRD6&rft_id=info:doi/10.1023/A:1015234318582&rft_dat=%3Cproquest_cross%3E405244721%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c350t-3b290fa74d4d0c57459ea949f1c7ec2bafa01ab69bdafb33cbcfbb1b0b3c1be03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=212453686&rft_id=info:pmid/12083629&rfr_iscdi=true |